Transgene SA
PAR:TNG
Transgene SA
PAR:TNG
Price:
1.328 EUR
-0.6%
Market Closed
Updated:
May 17, 2024
Transgene SA
Net Income (Common)
|
Transgene SA
Net Income (Common) Peer Comparison
Comparables:
VLA
NANO
IPH
ALCLS
ABVX
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Transgene SA
PAR:TNG
|
Net Income (Common)
-€22.3m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
6%
|
|
|
Valneva SE
PAR:VLA
|
Net Income (Common)
-€101.4m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-15%
|
|
|
Nanobiotix SA
PAR:NANO
|
Net Income (Common)
-€39.7m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-17%
|
|
|
Innate Pharma SA
PAR:IPH
|
Net Income (Common)
-€7.6m
|
CAGR 3-Years
51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
|
Cellectis SA
PAR:ALCLS
|
Net Income (Common)
-$101.1m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-3%
|
|
|
Abivax SA
PAR:ABVX
|
Net Income (Common)
-€147.7m
|
CAGR 3-Years
-58%
|
CAGR 5-Years
-56%
|
CAGR 10-Years
N/A
|
See Also
What is Transgene SA's Net Income (Common)?
Net Income (Common)
-22.3m
EUR
-22.3m
EUR
Based on the financial report for Dec 31, 2023, Transgene SA's Net Income (Common) amounts to -22.3m EUR.
What is Transgene SA's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
6%
6%
Over the last year, the Net Income (Common) growth was 32%. The average annual Net Income (Common) growth rates for Transgene SA have been -9% over the past three years , and 6% over the past ten years .
You don't have any saved screeners yet
